SCIENCE IN THE NEWS DAILY
Vaccine Doubles Brain Cancer Survival Time
from the Guardian (UK)
A vaccine that more than doubles the survival time of patients with the most common and aggressive form of brain cancer has been developed by scientists.
Early results from clinical trials suggest patients who received the vaccine lived for nearly three years after being diagnosed with glioblastoma multiforme.
Patients given traditional anti-cancer treatment, including a combination of surgery, chemotherapy and radiotherapy, typically survived for a little more than a year following diagnosis. John Sampson, a neurosurgeon at Duke University's brain tumour centre in North Carolina, who led the trial, said: "We're more than doubling the survival time in this group, and we have some patients who are four, five or six years out from diagnosis, which is virtually unheard of in these people."
Read more ...
Science in the Media
Newspapers:
Magazines and Web Sites:
The Science-Media Intersection:
Sign Up
... for Sigma Xi SmartBrief, a free daily summary of the latest news in scientific research, delivered straight to your in-box. Each story is summarized concisely and linked directly to the original source for further reading.
Click here to subscribe.
Subscribe to Our Content!
Visit our RSS Feeds page to choose among 13 customized feeds, or create a free My AmSci account to request an email notice whenever a specified author, department or discipline appears online.
Sending...
Your email has been sent